Latest Clostridium difficile Stories
-- Study Advances Development of Preventive Approach for C.
Data Demonstrate Potency and Selectivity of Targetable, Highly Precise Antibacterials with Applications in Bacterial Disease and Microbiome Research SOUTH SAN FRANCISCO, Calif., March
-- Supportive Evidence for No Active Enzyme Absorption into Bloodstream Observed in Phase 1 Studies -- ROCKVILLE, Md., March 19, 2015 /PRNewswire/ --
ROCKVILLE, Md., March 11, 2015 /PRNewswire/ -- Synthetic Biologics, Inc.
-- Conference Call Scheduled for Monday, March 16, 2015, at 8:30 a.m.
Jvion, the leader in clinical predictive algorithms, announced the development of a Clostridium Difficile (C Diff) use case to help clinicians reduce the risk of deadly infections inside and outside
Leading advocacy and disease-awareness nonprofits applauds Centers for Disease Control & Prevention's new study that calls attention to nearly 500,000 Americans afflicted with Clostridium
RIDGEWOOD, N.J., Feb.
More than 100,000 of these infections developed among residents of U.S. nursing homes ATLANTA, Feb. 26, 2015 /PRNewswire-USNewswire/ -- Clostridium difficile (C.
--Validates Ability of Vestex Active Barrier Apparel to Protect Healthcare Workers and Patients by Reducing Bacteria on Clothing that Can Cause Hospital Acquired Infections-- ORLANDO,
Clostridium difficile, also known as "CDF/cdf", or "C. diff", is a Gram-positive bacteria of the genus Clostridium that causes severe diarrhea and other intestinal disease when competing bacteria in the gut flora are wiped out by antibiotics. They are anaerobic, spore-forming rods and is the most serious cause of antibiotic-associated diarrhea and potentially to pseudomembranous colitis. C. difficile bacteria naturally resides in the gut of a small percentage of the adult population. Others...
- Large; stout; burly.